Article By:
Don Dion
Tuesday, August 30, 2016 12:05 PM EDT
The 25-day quiet period on Medpace comes to an end on September 5, 2016, allowing the firm's IPO underwriters to publish reports and recommendations for the first time since its IPO.
In this article: MEDP Also: CVD, ICLR, Q, INCR, PRAH
